arrow
J

Joseph H. Butterfield

Mayo Clinic
H指数:56
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence and mortality indicate sex differences in chronic rhinosinusitis with nasal polyposis

发病率和死亡率表明伴有鼻息肉的慢性鼻窦炎存在性别差异

2025-06-100
PRE
Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM
2024-12-012
OAAI
Mast cell activation syndrome: Current understanding and research needs

肥大细胞活化综合征: 当前的理解和研究需求

2024-08-010
PRE
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT

基线类胰蛋白酶的正常范围应为1至15 ng/mL,并涵盖患有h α t的健康个体

2023-10-0122
OAAI
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes
2022-10-1963
OAAI
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium
2022-08-0113
OAAI
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group
2022-08-0115
OAAI
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium
2022-08-0147
OAAI
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group
2022-08-0134
OAAI
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis
2022-08-0114
OAAI
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice
2022-08-0139
OAAI
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes
2022-05-0121
OAAI
Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal
2021-11-01169
OAAI
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
2021-11-0139
OAAI